One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

In the next 10 years, expect the company to do the same while benefiting from greater insurance coverage for CGM -- ...

Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...

Investing in attractive dividend growth stocks can lead to superior long-term returns. The two healthcare companies below ...

According to UBS, the company’s next major driver is the SURPASS cardiovascular outcomes trial. The bank added that Eli Lilly ...

The Howard County Board of Education is suing several Big Pharma companies for allegedly inflating insulin prices, affecting ...

Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction.

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...